vs

Side-by-side financial comparison of Red Rock Resorts, Inc. (RRR) and DENTSPLY SIRONA Inc. (XRAY). Click either name above to swap in a different company.

DENTSPLY SIRONA Inc. is the larger business by last-quarter revenue ($961.0M vs $507.3M, roughly 1.9× Red Rock Resorts, Inc.). Red Rock Resorts, Inc. runs the higher net margin — 16.3% vs -15.2%, a 31.5% gap on every dollar of revenue. On growth, DENTSPLY SIRONA Inc. posted the faster year-over-year revenue change (6.2% vs 1.9%). Over the past eight quarters, Red Rock Resorts, Inc.'s revenue compounded faster (2.1% CAGR vs 0.4%).

Wynn Resorts, Limited is an American publicly traded corporation based in Paradise, Nevada, that is a developer and operator of high-end hotels and casinos. It was founded in 2002 by former Mirage Resorts Chairman and CEO Steve Wynn and is now run by CEO Craig Billings. As of 2020, the company has developed six properties.

Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.

RRR vs XRAY — Head-to-Head

Bigger by revenue
XRAY
XRAY
1.9× larger
XRAY
$961.0M
$507.3M
RRR
Growing faster (revenue YoY)
XRAY
XRAY
+4.3% gap
XRAY
6.2%
1.9%
RRR
Higher net margin
RRR
RRR
31.5% more per $
RRR
16.3%
-15.2%
XRAY
Faster 2-yr revenue CAGR
RRR
RRR
Annualised
RRR
2.1%
0.4%
XRAY

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
RRR
RRR
XRAY
XRAY
Revenue
$507.3M
$961.0M
Net Profit
$82.7M
$-146.0M
Gross Margin
46.1%
Operating Margin
28.3%
-14.5%
Net Margin
16.3%
-15.2%
Revenue YoY
1.9%
6.2%
Net Profit YoY
-3.8%
66.0%
EPS (diluted)
$0.73
$-0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RRR
RRR
XRAY
XRAY
Q1 26
$507.3M
Q4 25
$511.8M
$961.0M
Q3 25
$475.6M
$904.0M
Q2 25
$526.3M
$936.0M
Q1 25
$497.9M
$879.0M
Q4 24
$495.7M
$905.0M
Q3 24
$468.0M
$951.0M
Q2 24
$486.4M
$984.0M
Net Profit
RRR
RRR
XRAY
XRAY
Q1 26
$82.7M
Q4 25
$44.7M
$-146.0M
Q3 25
$42.3M
$-427.0M
Q2 25
$56.4M
$-45.0M
Q1 25
$44.7M
$20.0M
Q4 24
$46.6M
$-430.0M
Q3 24
$29.0M
$-494.0M
Q2 24
$35.7M
$-4.0M
Gross Margin
RRR
RRR
XRAY
XRAY
Q1 26
Q4 25
46.1%
Q3 25
48.8%
Q2 25
52.4%
Q1 25
53.0%
Q4 24
49.3%
Q3 24
52.1%
Q2 24
51.9%
Operating Margin
RRR
RRR
XRAY
XRAY
Q1 26
28.3%
Q4 25
28.1%
-14.5%
Q3 25
27.6%
-24.1%
Q2 25
31.9%
-13.7%
Q1 25
31.0%
7.2%
Q4 24
28.7%
-56.2%
Q3 24
27.9%
-48.6%
Q2 24
28.8%
5.1%
Net Margin
RRR
RRR
XRAY
XRAY
Q1 26
16.3%
Q4 25
8.7%
-15.2%
Q3 25
8.9%
-47.2%
Q2 25
10.7%
-4.8%
Q1 25
9.0%
2.3%
Q4 24
9.4%
-47.5%
Q3 24
6.2%
-51.9%
Q2 24
7.3%
-0.4%
EPS (diluted)
RRR
RRR
XRAY
XRAY
Q1 26
$0.73
Q4 25
$0.74
$-0.74
Q3 25
$0.68
$-2.14
Q2 25
$0.95
$-0.22
Q1 25
$0.75
$0.10
Q4 24
$0.78
$-2.09
Q3 24
$0.48
$-2.46
Q2 24
$0.59
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RRR
RRR
XRAY
XRAY
Cash + ST InvestmentsLiquidity on hand
$326.0M
Total DebtLower is stronger
$2.3B
Stockholders' EquityBook value
$1.3B
Total Assets
$5.4B
Debt / EquityLower = less leverage
1.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RRR
RRR
XRAY
XRAY
Q1 26
Q4 25
$142.5M
$326.0M
Q3 25
$129.8M
$363.0M
Q2 25
$145.2M
$359.0M
Q1 25
$150.6M
$398.0M
Q4 24
$164.4M
$272.0M
Q3 24
$117.5M
$296.0M
Q2 24
$136.4M
$279.0M
Total Debt
RRR
RRR
XRAY
XRAY
Q1 26
Q4 25
$3.4B
$2.3B
Q3 25
Q2 25
Q1 25
Q4 24
$3.4B
$1.7B
Q3 24
Q2 24
Stockholders' Equity
RRR
RRR
XRAY
XRAY
Q1 26
Q4 25
$208.3M
$1.3B
Q3 25
$219.6M
$1.5B
Q2 25
$203.4M
$2.0B
Q1 25
$247.1M
$2.0B
Q4 24
$215.1M
$1.9B
Q3 24
$175.5M
$2.5B
Q2 24
$159.0M
$3.1B
Total Assets
RRR
RRR
XRAY
XRAY
Q1 26
Q4 25
$4.2B
$5.4B
Q3 25
$4.1B
$5.7B
Q2 25
$4.0B
$6.1B
Q1 25
$4.1B
$6.0B
Q4 24
$4.0B
$5.8B
Q3 24
$4.0B
$6.6B
Q2 24
$4.0B
$6.9B
Debt / Equity
RRR
RRR
XRAY
XRAY
Q1 26
Q4 25
16.30×
1.70×
Q3 25
Q2 25
Q1 25
Q4 24
15.84×
0.90×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RRR
RRR
XRAY
XRAY
Operating Cash FlowLast quarter
$101.0M
Free Cash FlowOCF − Capex
$60.0M
FCF MarginFCF / Revenue
6.2%
Capex IntensityCapex / Revenue
4.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$104.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RRR
RRR
XRAY
XRAY
Q1 26
Q4 25
$156.6M
$101.0M
Q3 25
$168.3M
$79.0M
Q2 25
$158.4M
$48.0M
Q1 25
$126.2M
$7.0M
Q4 24
$148.2M
$87.0M
Q3 24
$131.0M
$141.0M
Q2 24
$142.5M
$208.0M
Free Cash Flow
RRR
RRR
XRAY
XRAY
Q1 26
Q4 25
$77.7M
$60.0M
Q3 25
$74.6M
$40.0M
Q2 25
$80.3M
$16.0M
Q1 25
$58.0M
$-12.0M
Q4 24
$121.4M
$36.0M
Q3 24
$50.7M
$98.0M
Q2 24
$64.0M
$156.0M
FCF Margin
RRR
RRR
XRAY
XRAY
Q1 26
Q4 25
15.2%
6.2%
Q3 25
15.7%
4.4%
Q2 25
15.3%
1.7%
Q1 25
11.6%
-1.4%
Q4 24
24.5%
4.0%
Q3 24
10.8%
10.3%
Q2 24
13.1%
15.9%
Capex Intensity
RRR
RRR
XRAY
XRAY
Q1 26
Q4 25
15.4%
4.3%
Q3 25
19.7%
4.3%
Q2 25
14.9%
3.4%
Q1 25
13.7%
2.2%
Q4 24
5.4%
5.6%
Q3 24
17.2%
4.5%
Q2 24
16.2%
5.3%
Cash Conversion
RRR
RRR
XRAY
XRAY
Q1 26
Q4 25
3.51×
Q3 25
3.98×
Q2 25
2.81×
Q1 25
2.82×
0.35×
Q4 24
3.18×
Q3 24
4.53×
Q2 24
4.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RRR
RRR

Casino$340.5M67%
Food and beverage$90.3M18%
Room$45.5M9%
Other$26.2M5%
Native American management and development fees$4.7M1%

XRAY
XRAY

Essential Dental Solutions$372.0M39%
Equipment And Instruments$160.0M17%
Implants And Prosthetics$150.0M16%
CADCAM$139.0M14%
Wellspect Healthcare$88.0M9%
Orthodontics$52.0M5%

Related Comparisons